BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 8069204)

  • 41. Short-course treatment in pulmonary tuberculosis.
    Jindani A
    East Afr Med J; 1975 Sep; 52(9):472-80. PubMed ID: 53135
    [No Abstract]   [Full Text] [Related]  

  • 42. Results of a 12-month regimen for drug-resistant pulmonary tuberculosis.
    Pérez-Guzmán C; Vargas MH; Martínez-Rossier LA; Torres-Cruz A; Villarreal-Velarde H
    Int J Tuberc Lung Dis; 2002 Dec; 6(12):1102-9. PubMed ID: 12546119
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Empiric antituberculosis treatment: benefits for earlier diagnosis and treatment of tuberculosis.
    Anglaret X; Saba J; Perronne C; Lacassin F; Longuet P; Leport C; Vildé JL
    Tuber Lung Dis; 1994 Oct; 75(5):334-40. PubMed ID: 7841426
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [A controlled survey comparing 2 short-term therapeutic regimes in lymph node tuberculosis].
    Amrane R; Mazouni L; Boulahbal F; Abtroun N; Zidane C
    Rev Mal Respir; 1989; 6(1):53-7. PubMed ID: 2648510
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment of tuberculous masses in the neck.
    Deitel M; Saldanha CF; Borowy ZJ; Ronald AC; Krajden S
    Can J Surg; 1984 Jan; 27(1):90-3. PubMed ID: 6467109
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Short-course chemotherapy for tuberculosis in Chile. Operational considerations].
    Valenzuela P; Valenzuela MT
    Rev Med Chil; 1984 Mar; 112(3):287-9. PubMed ID: 6473970
    [No Abstract]   [Full Text] [Related]  

  • 47. [Short-term chemotherapy of pulmonary tuberculosis. Pilot study].
    Poppe de Figueiredo F; Brito AA; Laborne Valle JH; Tavares PM; Trannin PL
    Bull Int Union Tuberc; 1974; 49(1):411-7. PubMed ID: 4619561
    [No Abstract]   [Full Text] [Related]  

  • 48. [Treatment of primary tuberculosis].
    Gerbeaux J
    Rev Med Liege; 1974 Jan; 29(2):29-35. PubMed ID: 4846950
    [No Abstract]   [Full Text] [Related]  

  • 49. Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda.
    Bwire R; Borgdorff MW; Sticht-Groh V; Rieder HL; Kawuma HJ; Bretzel G; Rüsch-Gerdes S
    East Afr Med J; 1999 Jun; 76(6):307-13. PubMed ID: 10750516
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Preliminary results of initial short-term chemotherapy with INH, RMP and EMB in intermittent and biphasic administration (the 3 plus 6 experiment)].
    Anastasatu C; Bercea O; Barcan F; Stinghe R; Dinulică E; Marcovici M; Cristea M; Cărpinişan L; Gheorghiu M; Iancovici O; Ghinescu S
    Ftiziologia; 1974 May; 23(3):253-64. PubMed ID: 4842931
    [No Abstract]   [Full Text] [Related]  

  • 51. Tuberculous gumma in a patient with cervical lymphadenitis.
    Difonzo EM; Lotti L; Salvini C; Sestini S; Fabroni C
    Int J Dermatol; 2006 Dec; 45(12):1467-8. PubMed ID: 17184269
    [No Abstract]   [Full Text] [Related]  

  • 52. Tubercular oesophagocutaneous fistula.
    Vinodh BN; Sharma SK; Smith-Rohrberg D; Seith A
    Indian J Chest Dis Allied Sci; 2006; 48(3):209-11. PubMed ID: 18610681
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Preliminary use of ethambutol in the therapy of tuberculosis in children].
    Del Principe A; Caione C; Zamparelli F
    Ann Ist Carlo Forlanini; 1968; 28(1):42-73. PubMed ID: 5309678
    [No Abstract]   [Full Text] [Related]  

  • 54. [Severe course and contingent risk factors in optic neuropathy and myelopathy after tuberculostatics].
    Frisch IB; Kunze AK; Castro A; Krastel H; Meinck HM
    Ophthalmologe; 2003 Nov; 100(11):967-70. PubMed ID: 14669033
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmaceutical formulation of a fixed-dose anti-tuberculosis combination.
    Danckwerts MP; Ebrahim S; Pillay V
    Int J Tuberc Lung Dis; 2003 Mar; 7(3):289-97. PubMed ID: 12661846
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Myrin P in the combined treatment of tuberculosis].
    Sokolova GB; Semenova OV; Bogadel'nikova IV; Kunichan AD; Zeliger LR; Elistratova NA
    Antibiot Khimioter; 2002; 47(6):22-7. PubMed ID: 12422644
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Short course chemotherapy (9 months) for lymphnode tuberculosis.
    Behera D; Jindal SK
    Indian J Chest Dis Allied Sci; 1990; 32(1):73-4. PubMed ID: 2269501
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Antitubercular chemotherapy].
    Jouveshomme S; Dautzenberg B
    Rev Mal Respir; 1997 Dec; 14 Suppl 5():S88-104. PubMed ID: 9496594
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The treatment of superficial tuberculous lymphadenitis.
    Campbell IA
    Tubercle; 1990 Mar; 71(1):1-3. PubMed ID: 2196725
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Efficiency of an intensive stage of chemotherapy for tuberculosis in elderly and senile patients].
    Karachunskiĭ MA; Uvarova TE
    Probl Tuberk Bolezn Legk; 2004; (3):19-21. PubMed ID: 15338894
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.